Pfizer/BioNTech to seek emergency approval for virus vaccine Friday
Pfizer/BioNTech to seek emergency approval for virus vaccine Friday

Washington (AFP) – Pfizer and its partner BioNTech confirmed they will apply Friday for emergency use authorization for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.The vaccine has been developed with breathtaking speed — just 10 months after the genetic code of the novel coronavirus was first sequenced.The announcement had been expected for several days, after the companies said that a completed study of trials of the product showed it was 95 percent effective in protecting people from infection. The announcement also confi…

Read More

HEDGE accordingly